email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2638-5945

Open Access Journal of Oncology and Medicine

Review Article(ISSN: 2638-5945)

Citiscreen-A Combination of Precision Medicine and Artificial Intelligence in Cancer Screening Volume 5 - Issue 2

BM Petrikovsky*

  • NYU School of Medicine, USA

Received: November 30, 2021   Published: December 10, 2021

Corresponding author: NYU School of Medicine, USA

DOI: 10.32474/OAJOM.2021.05.000207


Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF


Precision medicine is a novel trend for treatment and prevention that emphasizes individual variability in genes, family history, and lifestyle for each person. This approach allows doctors to accurately predict which treatment and prevention strategies will work for an individual. It is in contrast to the one-size-fits-all approach used now where treatment and prevention are designed for the average person, not taking into account the differences between individuals. Although the term “precision medicine” is new, the concept has been known for years. For example, a person requiring blood transfusion is not given blood from a random donor; instead, the donor’s blood type is matched to the recipient. Precision medicine is different from boutique medicine. The latter is designed for wealthy consumers who are not interested to wait in line, have access to a health care provider during office hours only, use generic drugs, etc. Boutique or concierge medicine are for customers who do not rely on insurance only and look for alternative ways to maintain their health and wellness.

Introduction| CitiScreen steps of cancer screening| Preliminary Results of Citiscreen| References|


Online Submission System

Drag and drop files here


Browse Files
( For multiple files submission, zip them in a single file to submit. For file zipping software Download )